Kewaunee Scientific (KEQU) Cost of Revenue (2010 - 2026)

Kewaunee Scientific has reported Cost of Revenue for 17 years, with the latest figure at $50.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 4.23% year-over-year to $50.9 million; the trailing twelve-month figure through Jan 2026 stood at $204.5 million (up 27.37% YoY), and the FY2025 full-year result was $171.6 million, up 13.12% from the prior year.
• Cost of Revenue for Q1 2026 stood at $50.9 million, up from $50.4 million in the prior quarter.
• The five-year high for Cost of Revenue was $53.1 million in Q2 2025, with the low at $33.8 million in Q4 2024.
• Average Cost of Revenue over 5 years is $43.2 million, with a median of $43.6 million recorded in 2023.
• Year-over-year, Cost of Revenue sank 31.18% in 2024 and soared 48.99% in 2025.
• Tracing KEQU's Cost of Revenue over 5 years: stood at $45.9 million in 2022, then declined by 19.39% to $37.0 million in 2023, then fell by 8.54% to $33.8 million in 2024, then soared by 48.99% to $50.4 million in 2025, then increased by 0.95% to $50.9 million in 2026.
• The last three Cost of Revenue figures came in at $50.9 million (Q1 2026), $50.4 million (Q4 2025), and $50.2 million (Q3 2025), per Business Quant data.

Peer Comparison